These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 1391425)
1. Effect of a high concentration perfluorocarbon emulsion on platelet function. Smith DJ; Lane TA Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):1045-9. PubMed ID: 1391425 [TBL] [Abstract][Full Text] [Related]
2. Effect of high concentration perflubron emulsion on platelet function. Smith DJ; Lane TA Biomater Artif Cells Immobilization Biotechnol; 1993; 21(2):173-81. PubMed ID: 8318610 [TBL] [Abstract][Full Text] [Related]
3. Randomized safety studies of intravenous perflubron emulsion. I. Effects on coagulation function in healthy volunteers. Leese PT; Noveck RJ; Shorr JS; Woods CM; Flaim KE; Keipert PE Anesth Analg; 2000 Oct; 91(4):804-11. PubMed ID: 11004030 [TBL] [Abstract][Full Text] [Related]
4. Effect of two perfluorocarbon emulsions on reperfusion injury after coronary artery occlusion in rabbits. Hale SL; Hammerman H; Kloner RA Basic Res Cardiol; 1995; 90(5):404-9. PubMed ID: 8585862 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of endotoxin-mediated activation of endothelial cells by a perfluorocarbon emulsion. Lane T; Smith D; Wancewicz E; Funk R Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):1051-7. PubMed ID: 1382639 [TBL] [Abstract][Full Text] [Related]
6. High-dose droperidol protects against experimental coronary thrombosis in dogs and pigs and attenuates aggregation of porcine platelets and Ca2+ mobilization in human platelets. Bertha BG; Sill JC; Berger I; Folts JD; Milde JH Anesthesiology; 1993 Apr; 78(4):733-43. PubMed ID: 8466073 [TBL] [Abstract][Full Text] [Related]
7. Phagocytosis of a fluorescently labeled perflubron emulsion by a human monocyte cell line. Smith DJ; Kornbrust ES; Lane TA Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(4):1215-21. PubMed ID: 7849925 [TBL] [Abstract][Full Text] [Related]
8. The initial response of blood leukocytes to incubation with perfluorocarbon blood substitute emulsions. McDonagh PF; Wilson DS Artif Cells Blood Substit Immobil Biotechnol; 1995; 23(3):439-47. PubMed ID: 7493065 [TBL] [Abstract][Full Text] [Related]
9. Antagonism of the GPIIb/IIIa receptor with the nonpeptidic molecule BIBU52: inhibition of platelet aggregation in vitro and antithrombotic efficacy in vivo. Guth BD; Seewaldt-Becker E; Himmelsbach F; Weisenberger H; Müller TH J Cardiovasc Pharmacol; 1997 Aug; 30(2):261-72. PubMed ID: 9269956 [TBL] [Abstract][Full Text] [Related]
10. Perflubron emulsion delays blood transfusions in orthopedic surgery. European Perflubron Emulsion Study Group. Spahn DR; van Brempt R; Theilmeier G; Reibold JP; Welte M; Heinzerling H; Birck KM; Keipert PE; Messmer K; Heinzerling H; Birck KM; Keipert PE; Messmer K Anesthesiology; 1999 Nov; 91(5):1195-208. PubMed ID: 10551568 [TBL] [Abstract][Full Text] [Related]
11. The effect of the perfluorocarbon emulsion Oxycyte on platelet count and function in the treatment of decompression sickness in a swine model. Cronin WA; Senese AL; Arnaud FG; Regis DP; Auker CR; Mahon RT Blood Coagul Fibrinolysis; 2016 Sep; 27(6):702-10. PubMed ID: 26650458 [TBL] [Abstract][Full Text] [Related]
12. Compatibility of different colloid plasma expanders with perflubron emulsion: an intravital microscopic study in the hamster. Nolte D; Pickelmann S; Lang M; Keipert P; Messmer K Anesthesiology; 2000 Nov; 93(5):1261-70. PubMed ID: 11046215 [TBL] [Abstract][Full Text] [Related]
13. Effect of emulsion concentration on biodistribution of perflubron in tumor-bearing mice. Long DM; Witt BL; Escobar JA; Long RA Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):907-10. PubMed ID: 1391531 [TBL] [Abstract][Full Text] [Related]
14. Intralipid infusion into humans reduces in vitro platelet aggregation and alters platelet lipid composition. Aviram M; Deckelbaum RJ Metabolism; 1989 Apr; 38(4):343-7. PubMed ID: 2725276 [TBL] [Abstract][Full Text] [Related]
15. Randomized safety studies of intravenous perflubron emulsion. II. Effects on immune function in healthy volunteers. Noveck RJ; Shannon EJ; Leese PT; Shorr JS; Flaim KE; Keipert PE; Woods CM Anesth Analg; 2000 Oct; 91(4):812-22. PubMed ID: 11004031 [TBL] [Abstract][Full Text] [Related]
16. Intralipid rapidly attenuates the agonist-induced activation of rat platelets in vitro. Zhou L; Xu N; Nilsson A Thromb Res; 1997 Jan; 85(1):53-62. PubMed ID: 8983125 [TBL] [Abstract][Full Text] [Related]
17. Platelet responses to intravenous infusion of Intralipid in healthy volunteers. Jarnvig IL; Naesh O; Hindberg I; Behnke O; Bregengaad C; Wilhjelm B Am J Clin Nutr; 1990 Oct; 52(4):628-31. PubMed ID: 2144940 [TBL] [Abstract][Full Text] [Related]
18. Pulmonary gas trapping differences among animal species in response to intravenous infusion of perfluorocarbon emulsions. Leakakos T; Schutt EG; Cavin JC; Smith D; Bradley JD; Strnat CA; del Balzo U; Hazard DY; Otto S; Fields TK Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(4):1199-204. PubMed ID: 7849923 [TBL] [Abstract][Full Text] [Related]
19. Central hemodynamics and blood flow distribution during infusion of perflubron emulsion or its vehicle: effects in anesthetized dogs. Biro GP Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(4):1343-53. PubMed ID: 7849943 [TBL] [Abstract][Full Text] [Related]